Effect of dienogest-containing oral contraceptives on lipid metabolism (Q28212250)

1

0 references

J H Lee

2

0 references

E Kutschera

3

0 references

H H Bauer

4

0 references

C von Hayn

5

0 references

C Moore

6

0 references

U Mellinger

7

0 references

U H Winkler

8

0 references

W Gross

9

0 references

H Kuhl

Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study.

10

0 references

language of work or name

English

0 references

publication date

March 2002

0 references

published in

Contraception

0 references

volume

65

0 references

issue

3

0 references

page(s)

223-9

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Time-dependent alterations in lipid metabolism during treatment with low-dose oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

The metabolic impact of oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Progestins and oral contraceptive-induced lipoprotein changes: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Effects of two low-dose oral contraceptives on serum lipids and lipoproteins: differential changes in high-density lipoprotein subclasses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Effects of three low-dose oral contraceptive formulations on lipid metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Effects of seven low dose combined oral contraceptives on high density lipoprotein subfractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Effects of three combined oral contraceptive preparations containing desogestrel plus ethinyl estradiol on lipid metabolism in comparison with two levonorgestrel preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Short- and Long-Term Effects on Lipid Metabolism of Oral Contraceptives Containing 30 &mu;g Ethinylestradiol and 150 &mu;g Desogestrel or 3-Keto-Desogestrel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Investigation of the influence of two low-dose monophasic oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, on lipid metabolism in an open randomized tri

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Changes in lipid metabolism during 12 months of treatment with two oral contraceptives containing 30 micrograms ethinylestradiol and 75 micrograms gestodene or 150 micrograms desogestrel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

A new low-dose estrogen oral contraceptive combination: effect on endocrine parameters and lipid status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Preliminary report: kinetic studies on the modulation of high-density lipoprotein, apolipoprotein, and subfraction metabolism by sex steroids in a postmenopausal woman

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Mechanism of the hepatic lipase induced accumulation of high-density lipoprotein cholesterol by cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Hydrolysis of human plasma high density lipoprotein2-phospholipids and triglycerides by hepatic lipase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Plasma high-density lipoprotein concentration and subfraction distribution in relation to triglyceride metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Contraceptives containing desogestrel or levonorgestrel have different effects on serum lipoproteins and post-heparin plasma lipase activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Effects of two progestins with different androgenic properties on hepatic endothelial lipase and high density lipoprotein2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

The usefulness of information on HDL-cholesterol: potential pitfalls of conventional assumptions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Importance of levonorgestrel dose in oral contraceptives for effects on coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Oral contraceptive treatment decreases arterial low density lipoprotein degradation in female cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9

Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: role of the glucocorticoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900310-9